Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4

Status

Unknown 4Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 3Lymphoid 2Thoracic 1Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3Lymphoma 2Thymoma 1Leukemia 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × 68Ga-pentixafor × Clear all
NCT06086327 2023-10-17

Application of 68Ga-Pentixafor PET/CT for Thymoma

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
Thoracic

Thymoma

NCT04504526 2023-09-15

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

First Affiliated Hospital of Fujian Medical University

Phase EARLY_PHASE1 Unknown
50 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT05364177 2022-05-06

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
Plasma cell

Multiple Myeloma

NCT03436342 2019-12-27

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡